EU to buy up to 300 million doses of Pfizer-BioNTech vaccine
BRUSSELS (AP) - The European Commission will sign a deal to secure up to 300 million doses of the experimental coronavirus vaccine developed by BioNTech and Pfizer.
BRUSSELS (AP) - The European Commission will sign a deal to secure up to 300 million doses of the experimental coronavirus vaccine developed by BioNTech and Pfizer.